daunorubicin has been researched along with Hypospermatogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemez, P; Urbánek, V | 1 |
| Helminen, P; Koskimies, S; Lukka, M; Pakkala, S; Ruutu, T | 1 |
2 other study(ies) available for daunorubicin and Hypospermatogenesis
| Article | Year |
|---|---|
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients.
Topics: Acute Disease; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Oligospermia; Sperm Motility; Spermatozoa | 2005 |
Paternity after bone marrow transplantation following conditioning with total body irradiation.
Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; DNA; DNA Fingerprinting; Female; Humans; Hypogonadism; Infant, Newborn; Leukemia, Myeloid, Chronic-Phase; Male; Oligospermia; Paternity; Pregnancy; Radiation Injuries; Remission Induction; Spermatogenesis; Whole-Body Irradiation | 1994 |